Netherlands· NL-28dea3d8fe0f
Natrixam 1,5 mg / 5 mg, tabletten met gereguleerde afgifte
A amlodipin und diuretika product containing amlodipinebesilaat + indapamide 0-water, registered in Netherlands by Les Laboratoires Servier. The same ATC class is registered in 4 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Amlodipin und diuretika is registered in 4 of 19 countries.
Countries holding a registration under ATC C08GA02 (amlodipin und diuretika), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 3 of them publish a price we can compare per daily dose
Amlodipin und diuretika · ATC C08GA02
4 / 19 countries
- Belgiumprice
- Finlandprice
- Netherlands
- Polandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- AMLODIPINEBESILAAT + INDAPAMIDE 0-WATER
- Manufacturer
- Les Laboratoires Servier
- Country
- Netherlands (NL)
- ATC code
- C08GA02
- ATC class
- Amlodipin und Diuretika
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id112319
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Amlodipin und diuretika in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceNATRIXAM 1,5 mg/10 mg, comprimé à libération modifiéeDIFARMED (ESPAGNE)
- FinlandFlutensifLes Laboratoires Servier
- PolandTertens-AMLes Laboratoires Servier
- GermanyNatrixamLes Laboratoires Servier (Suresnes)
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Fludexam
- Bulgaria · Натриксам
- Germany · Natrixam
- Estonia · Flutensif, Natrixam
- France · Natrixam
- Croatia · Natrixam
- Hungary · Cardilopin Komb
- Italy · Frecanstal
- Lithuania · Natrixam
- Luxembourg · Natrixam
- Latvia · Tertensam
- Malta · Natrixam
- Poland · Tertens-Am
- Portugal · Flutensif, Natrixam
- Romania · Fludexam, Natrixam
- Slovenia · Nadexam
- Slovakia · Flutensif, Natrixam
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/edfbb162-45c0-4a7e-8288-89ccf2b9ac79 GET /v1/drugs/edfbb162-45c0-4a7e-8288-89ccf2b9ac79?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet met gereguleerde afgifte",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h112319_smpc.pdf",
"strength": null,
"atc_label": "Amlodipine and diuretics",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg112319",
"excipients": [
"CALCIUMWATERSTOFFOSFAAT 2-WATER (E 341)",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CROSCARMELLOSE NATRIUM (E 468)",
"GLYCEROL (E 422)",
"HYPROMELLOSE (E 464)",
"HYPROMELLOSE (Release controlling polymer)(E 464)",
"LACTOSE 1-WATER",
"MACROGOL 6000",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL, GEPREGELATINEERD",
"POVIDON (E 1201)",
"SILICIUMDIOXIDE (E 551)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"AMLODIPINEBESILAAT",
"INDAPAMIDE 0-WATER"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h112319.pdf",
"authorised_at": "2013/11/11",
"procedure_number": "NL/H/2637/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "112319",
"additional_monitoring": "N"
}See everything about amlodipin und diuretika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.